Literature DB >> 25918965

A study comparing standard and transepithelial collagen cross-linking riboflavin solutions: epithelial findings and pain scores.

Erdem Yuksel1, Shahin Novruzlu1, Mehmet C Ozmen1, Kamil Bilgihan1.   

Abstract

PURPOSE: To evaluate epithelial signs and pain after epithelial-on corneal collagen cross-linking (Epi-on CCL) with new transepithelial riboflavin formulation and epithelial-off corneal collagen cross-linking (Epi-off CCL) with standard riboflavin formulation and to compare pain and duration of epithelial healing between both techniques.
METHODS: Thirty-nine eyes of 39 patients undergoing Epi-on CCL and 39 eyes of 39 patients undergoing Epi-off CCL were evaluated. Corneal epithelial signs and durations of corneal epithelial healing and subjective pain scores after the procedures were recorded and compared between 2 groups.
RESULTS: Total epithelialization was observed after 2.7 ± 0.7 days in Epi-on CCL and 2.3 ± 0.4 days in Epi-off CCL (P = 0.006). The mean pain score on the first day was 3.1 ± 0.6 in Epi-on CCL and 2.3 ± 0.4 in Epi-off CCL with a significant difference (P = 0.0001).
CONCLUSION: The epithelial damage was observed in both procedures; also, the epithelial healing time was longer in Epi-on CCL and it is of great importance that the patients should have therapeutic contact lenses until the epithelium heals in both procedures. The Epi-off CCL group had less pain scores than the Epi-on CCL group and more pain problems after Epi-on CCL still remains. The patient should be informed about pain, even if the Epi-on CCL procedure was performed.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25918965     DOI: 10.1089/jop.2014.0090

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  6 in total

1.  Early epithelial complications of accelerated trans-epithelial corneal crosslinking in treatment of keratoconus: a case series.

Authors:  Sharon S W Chow; Tommy C Y Chan; Ian Y H Wong; Michelle C Y Fan; Jimmy S M Lai; Alex L K Ng
Journal:  Int Ophthalmol       Date:  2017-10-10       Impact factor: 2.031

2.  The Effect of Sodium Iodide on Stromal Loading, Distribution and Degradation of Riboflavin in a Rabbit Model of Transepithelial Corneal Crosslinking.

Authors:  Roy S Rubinfeld; Glenwood G Gum; Jonathan H Talamo; Edward C Parsons
Journal:  Clin Ophthalmol       Date:  2021-05-11

3.  Transepithelial versus epithelium-off corneal crosslinking for progressive keratoconus.

Authors:  Sueko M Ng; Mark Ren; Kristina B Lindsley; Barbara S Hawkins; Irene C Kuo
Journal:  Cochrane Database Syst Rev       Date:  2021-03-23

Review 4.  Complications of corneal collagen cross-linking.

Authors:  Richa Agarwal; Parul Jain; Ritu Arora
Journal:  Indian J Ophthalmol       Date:  2022-05       Impact factor: 2.969

5.  Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 Infection.

Authors:  Ana Castro-Balado; Cristina Mondelo-García; Letricia Barbosa-Pereira; Iria Varela-Rey; Ignacio Novo-Veleiro; Néstor Vázquez-Agra; José Ramón Antúnez-López; Enrique José Bandín-Vilar; Raquel Sendón-García; Manuel Busto-Iglesias; Ana Rodríguez-Bernaldo de Quirós; Laura García-Quintanilla; Miguel González-Barcia; Irene Zarra-Ferro; Francisco J Otero-Espinar; David Rey-Bretal; José Ramón Lago-Quinteiro; Luis Valdés-Cuadrado; Carlos Rábade-Castedo; María Carmen Del Río-Garma; Carlos Crespo-Diz; Olga Delgado-Sánchez; Pablo Aguiar; Gema Barbeito-Castiñeiras; María Luisa Pérez Del Molino-Bernal; Rocío Trastoy-Pena; Rossana Passannante; Jordi Llop; Antonio Pose-Reino; Anxo Fernández-Ferreiro
Journal:  Pharmaceutics       Date:  2021-03-05       Impact factor: 6.321

6.  Comparison of ocular discomfort after three different epithelial debridement techniques for corneal collagen cross-linking in keratoconus treatment.

Authors:  Hosamadden Alkayid; Leyla Asena; Aslihan Yüce; Meriç Yavuz Çolak; Dilek Dursun Altınörs
Journal:  Ther Adv Ophthalmol       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.